Tia L. Bush - 24 May 2023 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Quality Officer
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
24 May 2023
Net transactions value
-$35,865
Form type
4
Filing time
26 May 2023, 17:01:04 UTC
Previous filing
04 Apr 2023
Next filing
03 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Sale $22,425 -5,000 -62% $4.48 3,000 24 May 2023 By spouse F1
transaction CNTA Ordinary Shares Sale $13,440 -3,000 -100% $4.48 0 24 May 2023 By spouse F1
holding CNTA Ordinary Shares 157,102 24 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.